Main Page
About US
Director Message
No. Decision and Establashment Date
vision & mission
Our objectives
Our achievements
Organization Chart
Administration
Executive Board
Administrative Board
Scientific Advisor Committee
Postgraduate Committee
Ethical Committee
Elite Student Program Committee
Administrative Unit
Secretary Unit
Employment Unit
Ordering and Purchasing Unit
IT Unit
Financial Unit
Public Relations and Marketing Unit
Transportation Unit
Researchers
Senior Staff
Research Leaders
Research Staff
Technical Staff Labs
Research Programs
About Research Programs
Biobanking & Biospecimen Research Program
Cancer Genomic Research Program
Functional & Developmental Genomics Research Progr
Genomic Screening Research Program
Neurogenetic Research Program
Pharmacogenomics Research Program
Tissue Culture & Regenerative Medicine Research
Research Service Units
About Research Service Units
Biobanking Unit
Bioimaging Unit
Bioinformatics Unit
Biomedical Engineering Unit
Diagnostic & Genomic Medicine Unit (DGMU)
Cytogenetic Service Unit
Molecular Service Unit
Flowcytometry Unit
Genetic Counselling Unit
High-Throughput Sequencing Unit
Histopathology Unit
Microarray (Affymetrix) Unit
Microarray (Agilent) Unit
Pharmacogenomics & Drug Discovery Unit
Preimplantation Genetic Diagnosis Unit
Proteomics and Metabolomics Unit
Quantitative Genotyping Unit
Teratogenecity & Toxicity Unit
Tissue Culture Unit
Education & Outreach Program
About Education & Outreach Program
Master of Science Program
About the Program
Master Students
Doctor of Philosophy Program
About the Program
Ph.D. Students
Training Program
About Program
Specialized Training Program in Clinical Cyto.
Public Awareness Program
Collaborations
About Collaborations
National Level Collaborations
International Level Collaborations
Quality Management Program
About Quality Management Program
QMP Outline
QMP Aims and Function
Publications
CEGMR Publication List
Submit Publication Permission Request
CEGMR Booklets
CEGMR Newsletter
CEGMR Workshops
Conferences and Seminars
CEGMR Training Programs
Conferences & Workshops
Conferences
Workshops
Seminars and Training Courses
Parteners
Academic Parteners
National
International
Commercial Parteners
National
International
Related Links
Government
Journals
Non-Governmental Organizations
International Organizations
Medical Dictionaries
Search Engines for Researchers
PhotoAlbum
Files
Contact Us
Center map
Site Map
Latest News
Our Events
CEGMR Research
Research
Application for Employment
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Center of Excellence In Genomic Medicine Research
Document Details
Document Type
:
Article In Journal
Document Title
:
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Document Language
:
English
Abstract
:
The candidate tumor suppressor gene RASSF1A is inactivated in many types of adult and childhood cancers. However, the mechanisms by which RASSF1A exerts its tumor suppressive functions have yet to be elucidated. To this end, we performed a yeast two-hybrid screen to identify novel RASSF1A-interacting proteins in a human brain cDNA library. Seventy percent of interacting clones had homology to microtubule-associated proteins, including MAP1B and VCY2IP1/C19ORF5. RASSF1A association with MAP1B and VCY2IP1/C19ORF5 was subsequently confirmed in mammalian cell lines. This suggested that RASSF1A may exert its tumor-suppressive functions through interaction with the microtubules. We demonstrate that RASSF1A associates with the microtubules, causing them to exist as hyperstabilized circular bundles. We found that two naturally occurring tumor-associated missense substitutions in the RASSF1A coding region, C65R and R257Q, perturb the association of RASSF1A with the microtubules. The C65R and R257Q in addition to VCY2IP1/C19ORF5 showed reduced ability to induce microtubule acetylation and were unable to protect the microtubules against the depolymerizing action of nocodazole. In addition, wild-type RASSF1A but not the C65R or the R257Q is able to block DNA synthesis. Our data identify a role for RASSF1A in the regulation of microtubules and cell cycle dynamics that could be part of the mechanism(s) by which RASSF1A exerts its growth inhibition on cancer cells.
ISSN
:
1538-7445
Journal Name
:
CANCER RESEARCH
Volume
:
64
Issue Number
:
12
Publishing Year
:
1425 AH
2004 AD
Article Type
:
Article
Added Date
:
Monday, April 26, 2010
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
فريدة لطيف
Latif, Farida
Investigator
Doctorate
flatif@hgmp.mrc.ac.uk
أشرف دلول
Dallol, Ashraf
Researcher
Doctorate
Back To Researches Page